AtonRa Partners’s BioNTech BNTX Stock Holding History

AtonRa Partners’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$441K	Sell	4,175 -532	-11%	-$53.6K	0.88%	44
2023 Q3	$511K	Sell	4,707 -1,007	-18%	-$111K	1.07%	26
2023 Q2	$617K	Sell	5,714 -175	-3%	-$19.7K	0.95%	32
2023 Q1	$734K	Sell	5,889 -507	-8%	-$69.6K	1.07%	29
2022 Q4	$961K	Sell	6,396 -2,276	-26%	-$350K	1.22%	25
2022 Q3	$1.17M	Sell	8,672 -44	-0.5%	-$6.73K	1.15%	28
2022 Q2	$1.3M	Sell	8,716 -4,444	-34%	-$679K	1.2%	25
2022 Q1	$2.25M	Sell	13,160 -174	-1%	-$29.2K	1.22%	26
2021 Q4	$3.44M	Sell	13,334 -841	-6%	-$230K	1.19%	30
2021 Q3	$3.87M	Sell	14,175 -3,573	-20%	-$1.14M	1.29%	24
2021 Q2	$3.97M	Buy	17,748 +3,507	+25%	+$661K	1.46%	15
2021 Q1	$1.55M	Buy	14,241 +2,291	+19%	+$243K	0.69%	57
2020 Q4	$974K	Buy	+11,950	New	+$1.17M	0.48%	66

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

AtonRa Partners's BNTX Position: Q4 2023 in Review

AtonRa Partners reduced its BioNTech (BNTX) stake by 11% in Q4 2023, selling an estimated $53.6K and leaving 4,175 shares worth $441K. The position accounts for 0.88% of the portfolio, ranked #44.

AtonRa Partners first reported a position in BNTX in Q4 2020 and has held it in 13 quarters since. The position peaked at $3.97M in Q2 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

AtonRa Partners held 4,175 shares of BioNTech worth $441K as of Q4 2023.
AtonRa Partners sold 532 BioNTech shares in Q4 2023, an estimated $53.6K.
BioNTech made up 0.88% of AtonRa Partners's portfolio in Q4 2023, its #44 holding.
AtonRa Partners first reported a position in BioNTech in Q4 2020 and has held it in 13 quarters since.
AtonRa Partners's BioNTech position peaked at $3.97M in Q2 2021.
282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.